SI

Sibylla

Trento, IT · 7 known investors

sibyllabiotech.it ↗

Sibylla Biotech develops PPI-FIT, a drug discovery technology that uses quantum physics and mathematical modeling to characterize protein folding pathways at atomic resolution. The company focuses on protein misfolding diseases, particularly prion diseases.

Investors · 7

3B

3B Future Health Fund✓ verifiedMonaco · $12M

CD

CDP Venture Capital✓ verifiedRome

SE

Seroba Life Sciences✓ verifiedDublin · $540K – $7.6M

V-

V-Bio Ventures✓ verifiedGhent · $270K – $2.2M

VE

Vertis SGR✓ verifiedNaples

VI

VI Partners✓ verifiedAltendorf · $2.2M – $4.5M

CL

Claris VenturesTurin